Statin Intensity and Clinical Outcome in Patients with Stable Coronary Artery Disease and Very Low LDL-Cholesterol

about

Statin Intensity and Clinical Outcome in Patients with Stable Coronary Artery Disease and Very Low LDL-Cholesterol

Item

http://www.wikidata.org/entity/Q36185746

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Statin Intensity and Clinical ...... e and Very Low LDL-Cholesterol

@ast

Statin Intensity and Clinical ...... e and Very Low LDL-Cholesterol

@en

type

Item

label

Statin Intensity and Clinical ...... e and Very Low LDL-Cholesterol

@ast

Statin Intensity and Clinical ...... e and Very Low LDL-Cholesterol

@en

prefLabel

Statin Intensity and Clinical ...... e and Very Low LDL-Cholesterol

@ast

Statin Intensity and Clinical ...... e and Very Low LDL-Cholesterol

@en

P1476

Statin Intensity and Clinical ...... e and Very Low LDL-Cholesterol

@en

P2093

Byeong-Keuk Kim

http://www.w3.org/2001/XMLSchema#string

Chi-Yoon Oum

http://www.w3.org/2001/XMLSchema#string

Eung Ju Kim

http://www.w3.org/2001/XMLSchema#string

Geu-Ru Hong

http://www.w3.org/2001/XMLSchema#string

Jaewon Oh

http://www.w3.org/2001/XMLSchema#string

Jung-Sun Kim

http://www.w3.org/2001/XMLSchema#string

Myeong-Ki Hong

http://www.w3.org/2001/XMLSchema#string

Namsik Chung

http://www.w3.org/2001/XMLSchema#string

Sang-Hak Lee

http://www.w3.org/2001/XMLSchema#string

Seung-Jin Oh

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial.

Additive beneficial effects of valsartan combined with rosuvastatin in the treatment of hypercholesterolemic hypertensive patients

P304

e0166246

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0166246

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27824924

http://www.w3.org/2001/XMLSchema#string

P932

5100958

http://www.w3.org/2001/XMLSchema#string